This topic contains a solution. Click here to go to the answer

Author Question: An antiemetic that potentiates the depressant effects on the CNS of narcotics, sedatives or ... (Read 77 times)

ETearle

  • Hero Member
  • *****
  • Posts: 580
An antiemetic that potentiates the depressant effects on the CNS of narcotics, sedatives or hypnotics, and alcohol and no longer used commonly by emergency medical services is:
 
  a. Ondansetron (Zofran)
  b. Dolasetron (Anzemet)
  c. Promethazine (Phenergan)
  d. Prochlorperazine (Compazine)

Question 2

A person with type A blood cannot receive type O blood.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

softEldritch

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

c
Rationale: a. Zofran is a serotonin antagonist having less effect on CNS depressants.
b. Dolastron is a serotonin antagonist having less effect on CNS depression.
c. Correct.
d. Prochlorperazine has weak anticholinergic properties having less effect on CNS depression.

Answer to Question 2

FALSE





 

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

For a complete list of videos, visit our video library